Dr Skip Lenz shares his LDN Experience on the LDN Radio Show

Pharmacist Dr. Skip Lenz from United States talks about his experience prescribing Low Dose Naltrexone.

Approximately in December of 1999, I had a patient who was on another product for Multiple Sclerosis who asked me to walk into this new thing, Naltrexone low dose.

There was a doctor up in New York who was prescribing it and was getting tremendous results with MS Patients. So I looked into it and I had several conversations with dr. Bahari, who was a clinical innovator of the year. And the rest literally is history.

We're now always down 100 to 200 scripts at the end of the week.

Back in 1999 we did a clinical study to close to a thousand MS patients and 83% not had an exacerbation in greater than three years.

I started taking LDN for Rheumatoid Arthritis about six years ago for prophylaxis. I'm a pharmacist. I have access to literally anything, nothing worked very well.  After three months, four months after I started my LDN, I wasn't taking Ibuprofen anymore.

LDN still hasn't been FDA approved. I was skeptical the first year. This is one of the reasons why I did our survey. Is working so therefore that's the reason why I am an advocate of it.

I've been a pharmacist since 1973. First of all, I have a conversation with my patients about what they're doing and what have they tried, what are their symptoms, what are their expectations of LDN. It's again, my experience that sometimes in a niche stuation, whatever the disease is in an acute situation, you may or may not get the result that you expect in a chronic situation and you're generally going to judge the expected result.

My experience it's either going to work somewhat in six months or it's not going to work at all. What I mean by somewhat is that you might only be getting, 20, 30, 40% of the results that you are expecting in six months, that you should be getting some sort of results.

Summary from Dr. Skip Lenz's interview. Listen to the video for the full interview.